Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAFLD, Non-alcoholic Fatty Liver Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT02458586
What this trial is testing

Ernährungs-Interventions-Fettleber-Studie (Interventional Study on Nutritional Effects on NAFLD)

Who this might be right for
NAFLDObesityPrediabetes+1 more
German Institute of Human Nutrition 40
Not applicableLooking for participantsNCT05463796
What this trial is testing

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Who this might be right for
Cancer RiskCancer Predisposition SyndromeHereditary Cancer Prediction+28 more
Dana-Farber Cancer Institute 5,000
Early research (Phase 1)Looking for participantsNCT06354088
What this trial is testing

Human Models of Selective Insulin Resistance: Alpelisib, Part I

Who this might be right for
Insulin ResistancePrediabetic StateOverweight and Obesity+1 more
Columbia University 32
Post-approval studies (Phase 4)Study completedNCT03910361
What this trial is testing

Efficacy and Safety of Evoglitin in Patients With Type 2 Diabetes and Non-alcoholic Fatty Liver Diseases

Who this might be right for
Type2 DiabetesNon-Alcoholic Fatty Liver Disease
Dong-A ST Co., Ltd. 51
Early research (Phase 1)Study completedNCT03513588
What this trial is testing

2-Week Study In People With Nonalcoholic Fatty Liver Disease

Who this might be right for
Non-alcoholic SteatohepatitisNon-alcoholic Fatty Liver Disease
Pfizer 48
Testing effectiveness (Phase 2)Study completedNCT05506488
What this trial is testing

Dasatinib and Quercetin to Treat Fibrotic Non-alcoholic Fatty Liver Disease

Who this might be right for
NAFLDNASH With FibrosisLiver Fibrosis
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 30
Not applicableActive Not RecruitingNCT04707651
What this trial is testing

Formula Diet Treatment for NASH Patients.

Who this might be right for
Steatohepatitis, Nonalcoholic
West German Center of Diabetes and Health 20
Not applicableStudy completedNCT07268937
What this trial is testing

Assessment of Hepatic Steatosis Using Dedicated Software Implemented on Ultrasound Devices

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
Fondazione IRCCS Policlinico San Matteo di Pavia 25
Post-approval studies (Phase 4)Study completedNCT05042245
What this trial is testing

The Efficacy and Safety of Ornithine Aspartic Acid Granules in NAFLD Against Silymarin Capsules

Who this might be right for
Non-alcoholic Fatty Liver Disease
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 237
Testing effectiveness (Phase 2)Study completedNCT05415722
What this trial is testing

DUET Study: A Clinical Study to Evaluate the Safety, Efficacy, Pharmacokinetics and Pharmacodynamics of Orally Administered TERN-501 as Monotherapy and in Combination With TERN-101 in Noncirrhotic Adults With Presumed Non-Alcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
Terns, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 162
Testing effectiveness (Phase 2)UnknownNCT03205345
What this trial is testing

Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis

Who this might be right for
Decompensated Cirrhosis
Conatus Pharmaceuticals Inc. 210
Not applicableEnded earlyNCT03914495
What this trial is testing

The Role of Microbiome Reprogramming on Liver Fat Accumulation

Who this might be right for
NAFLD
AdventHealth Translational Research Institute 57
Testing effectiveness (Phase 2)Study completedNCT07104786
What this trial is testing

Comparison of Effectiveness of Obeticholic Acid With Vitamin E in Patients of Non-alcoholic Fatty Liver Disease

Who this might be right for
Non Alcoholic Fatty Liver Disease
King Edward Medical University 90
Not applicableStudy completedNCT04800094
What this trial is testing

Pediatric Liver Fat Quantification (LFQ) Phase 2 Pilot Study

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseNon-Alcoholic Steatohepatitis
Philips Clinical & Medical Affairs Global 30
Not applicableStudy completedNCT01747772
What this trial is testing

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

Who this might be right for
Chronic Liver DiseaseNon-Alcoholic Fatty Liver DiseaseHepatitis C Virus (HCV) Coinfection+2 more
Massachusetts General Hospital 180
Not applicableLooking for participantsNCT04690972
What this trial is testing

"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".

Who this might be right for
Chronic Liver Disease and CirrhosisLiver CancerNon-Alcoholic Fatty Liver Disease+4 more
Institut National de la Santé Et de la Recherche Médicale, France 800
Not applicableLooking for participantsNCT03587831
What this trial is testing

Vertical Sleeve Gastrectomy and Lifestyle Modification for the Treatment of Non-Alcoholic Steatohepatitis

Who this might be right for
NASH - Nonalcoholic Steatohepatitis
University of Minnesota 48
Not applicableActive Not RecruitingNCT02754037
What this trial is testing

Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)Non-alcoholic Steatohepatitis (NASH)
University of California, Davis 120
Not applicableLooking for participantsNCT07241195
What this trial is testing

A Community-based Prospective Cohort Study on Metabolic Dysfunction-Associated Fatty Liver Disease in Older Adults: From Metabolic Trajectories to Extrahepatic Outcomes

Who this might be right for
NAFLD and NASHNAFLD( Non-alcoholic Fatty Liver Disease )NAFLD Cirrhosis
The Affiliated Hospital of Hangzhou Normal University 20,000
Not applicableNot Yet RecruitingNCT06908122
What this trial is testing

Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences

Who this might be right for
Non-alcoholic Fatty Liver Disease
Assiut University 100
Next Page